SmartCells
Insulin and polymer-based products for the treatment of diabetes, fertility, thyroid, and growth hormone deficiencies.
Launch date
Employees
Market cap
-
Enterprise valuation
€455m (Public information from Dec 2010)
Beverly Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$1.5m | Grant | ||
$4.1m | Series D | ||
| N/A | $1.1m | Debt | |
$4.1m | Series D | ||
$500m Valuation: $500m | Acquisition | ||
| Total Funding | €10.8m | ||